DPS Group Completes Work on New Virotherapy Manufacturing Facility for Vibalogics

SourceBoston Real Estate Times
Date Published03/03/2022
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Vibalogics GMP
Parent companyDPS Group
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2022
Domestically, the work will be done:In-house
Capital investment ($):150
Country(ies) from which reshored:Germany
City reshored to:Boxborough
State(s) reshored to:MA
If relevant, work nearshored to:-
Product(s) reshoredviral vector gene therapy, vaccines
What domestic positive factors made reshoring more attractive?Automation/technology
Find Reshoring Articles